Drugs online research references











  • Effect of low doses of angiotensin II perfusion on the hypotensive action of captopril in anaesthetized normotensive and spontaneously hypertensive rats.
  • Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase.
  • Role of basal nitric oxide synthesis in vasoconstrictor hyporeactivity in the perfused rat hindlimb after myocardial infarction: effect of captopril.
  • Interactions of the renin-angiotensin system and neuronal nitric oxide synthase in regulation of cyclooxygenase-2 in the macula densa.
  • Inhibition of kinin degradation on the luminal side of renal tubules reduces high blood pressure in deoxycorticosterone acetate salt-treated rats.
  • Determination of captopril and its degradation products by capillary electrophoresis.
  • Utilization of carbon disulphide for the analytical determination of betahistine hydrochloride and captopril in their pharmaceutical preparations.
  • Regional and temporal profiles of phorbol 12,13-dibutyrate binding after myocardial infarction in rats: effects of captopril treatment.
  • Improvement in fatty acid utilization in relation to a change in left ventricular hypertrophy in spontaneously hypertensive rats.
  • Antiangiogenic effects of S-nitrosocaptopril crystals as a nitric oxide donor.
  • A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II
  • The role of endothelin, protein kinase C and free radicals in the mechanism of the post-ischemic endothelial dysfunction in guinea-pig hearts.
  • Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
  • Free radical scavenging and copper chelation: a potentially beneficial action of captopril.
  • Effect of kininase II inhibitors on bradykinin-stimulated bovine sperm motility.
  • Cardiac effects of local angiotensin-converting enzyme inhibition in hypertensive patients.
  • Persistent improvement of cardiovascular risk factors in spontaneously hypertensive rats following early short-term captopril treatment.
  • Pumpkin-seed oil modulates the effect of felodipine and captopril in spontaneously hypertensive rats.
  • Effect of losartan on human platelet activation by thromboxane A2
  • Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy.
  • Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
  • Usefulness of captopril in the management of hypertension after renal transplantation.
  • Amiodarone induces apoptosis of human and rat alveolar epithelial cells in vitro.
  • Cardiac infarcts increase sodium transporter transcripts (rBSC1) in the thick ascending limb of Henle.
  • Effect of captopril on skeletal muscle angiogenic growth factor responses to exercise.
  • The influence of angiotensin-converting enzyme inhibitors on collagen content of the aorta wall in experimental hypercholesterolemia
  • Coumarin-Ser-Asp-Lys-Pro-OH, a fluorescent substrate for determination of angiotensin-converting enzyme activity via high-performance liquid chromatography.
  • CGRP(2) receptor in the internal anal sphincter of the rat: implications for CGRP receptor classification.
  • Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker.
  • Activation of neurokinin NK(2) receptors by tachykinin peptides causes contraction of uterus in pregnant women near term.
  • Amperometric biosensors/sequential injection analysis system for simultaneous determination of S- and R-captopril.
  • Mapping the active site of angiotensin-converting enzyme by transferred NOE spectroscopy.
  • Antihypertensive effect of the oral angiotensin I-converting enzyme inhibitor in long-term treatment of hypertensive patients.
  • Aspirin renography in the diagnosis of renovascular hypertension: a comparative study with captopril renography.
  • Mechanisms mediating substance P-induced contraction in the rat iris in vitro.
  • Mechanisms of 5-aminolevulinic acid uptake at the choroid plexus.
  • Angiotensin I-converting enzyme isoforms (high and low molecular weight) in urine of premature and full-term infants.
  • Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs.
  • Participation of kinins in the captopril-induced inhibition of intimal hyperplasia caused by interruption of carotid blood flow in the mouse.
  • Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation.
  • Effect of helicokinins and ACE inhibitors on water balance and development of Heliothis virescens larvae.
  • Wound healing: captopril, an angiogenesis inhibitor, and Staphylococcus aureus peptidoglycan.
  • Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction.
  • Kinins and thrombolysis.
  • Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
  • Captopril floating and/or bioadhesive tablets: design and release kinetics.
  • Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital.
  • Effects of angiotensin-converting enzyme inhibitors and sclerotherapy on portal hemodynamics in patients with portal hypertension.
  • Indirect determination of captopril by AAS.
  • Effect of inhibition of angiotensin converting enzyme on hypertension following kidney transplantation
  • MET-88, a gamma-butyrobetaine hydroxylase inhibitor, improves cardiac SR Ca2+ uptake activity in rats with congestive heart failure following myocardial infarction.
  • Pharmacotherapy in patients with ischemic heart disease and diabetes mellitus in 1998 in the Czech Republic
  • Inhibition of angiotensin-converting enzyme by captopril: a novel approach to reduce ischemia-reperfusion injury after lung transplantation.
  • Effects of aqueous extracts of Apocynum venetum leaves on spontaneously hypertensive, renal hypertensive and NaCl-fed-hypertensive rats.
  • Reduction of sodium taste threshold during treatment with captopril in essential hypertension.
  • Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals.
  • Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
  • Electrophoretic control of captopril-bovine serum albumin conjugate bond
  • Reduction of cardiac endothelin-1 by angiotensin II type 1 receptor antagonist in viral myocarditis of mice.
  • Changes in contractile protein gene expression with ageing and with captopril-induced regression of hypertrophy in the spontaneously hypertensive rats.
  • Antihypertensive agents: angiotensin converting enzyme inhibitors. 1-3-(Acylthio)-3-aroylpropionyl-L-prolines.
  • Acute effects of bradykinin on cerebral microvascular permeability in the anaesthetized rat.
  • The influence of angiotensin converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet-induced hypercholesterolemia.
  • Does captopril change oxidative stress in puromycin aminonucleoside nephropathy?
  • Involvement of angiotensin II and endothelin-1 in the development of submandibular gland hypertrophy in response to isoproterenol in rats.
  • Isosorbide dinitrate tolerance in the treatment of patients with angina pectoris and the effect of addition of captopril on therapeutic results
  • Testosterone increases blood pressure and cardiovascular and renal pathology in spontaneously hypertensive rats.
  • Cardiac ischemia oxidizes regulatory thiols on ryanodine receptors: captopril acts as a reducing agent to improve Ca2+ uptake by ischemic sarcoplasmic reticulum.
  • Expression of a renin/GFP transgene in mouse embryonic, extra-embryonic, and adult tissues.
  • Effects of the AT1 receptor antagonist on adhesion molecule expression in leukocytes and brain microvessels of stroke-prone spontaneously hypertensive rats.
  • Evaluation of pharmacokinetics and pharmacodynamics of captopril from transdermal hydrophilic gels in normotensive rabbits and spontaneously hypertensive rats.
  • In vitro tannin acantholysis.
  • Expression of the skin-homing receptor in peripheral blood lymphocytes from subjects with nonimmediate cutaneous allergic drug reactions.
  • In vitro degradation of the Neb-Trypsin modulating oostatic factor (Neb-TMOF) in gut luminal content and hemolymph of the grey fleshfly, Neobellieria bullata.
  • Bradykinin (B2) independent effect of captopril on the development of pressure overload cardiac hypertrophy.
  • Liquid extraction and HPLC-DAD assay of hydrochlorothiazide from plasma for a bioequivalence study at the lowest therapeutic dose.
  • The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition.
  • Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
  • Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction.
  • Participation of angiotensin II in pressor response and norepinephrine release to spinal nerve stimulation in pithed rats.
  • Effect of renin-angiotensin system blockade on the expression of the angiotensinogen gene and induction of hypertrophy in rat kidney proximal tubular cells.
  • Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction.
  • Captopril inhibits the production of tumor necrosis factor-alpha by human mononuclear cells in patients with congestive heart failure.
  • Renal hemodynamic effects of captopril and doxazosin during slight physical activity in hypertensive patients with type-1 diabetes mellitus.
  • Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells.
  • Chronic losartan treatment decreases angiotensin II-mediated facilitation of noradrenaline release in the caudal artery of spontaneously hypertensive rats.
  • Neutral endopeptidase and angiotensin converting enzyme inhibitors potentiate kinin-induced contraction of ferret trachea.
  • Cerebrovascular reactivity to angiotensin and angiotensin-converting enzyme activity in cerebrospinal fluid.
  • Expression of Ca(2+) Transport Genes in Platelets and Endothelial Cells in Hypertension.
  • Efficacy of quadropril (spirapril) vs capropril in treatment of essential hypertension
  • Pressor responsiveness to angiotensin in renovascular and steroid hypertension.
  • Effect of thiol drugs on the oxidative hemolysis in human erythrocytes.
  • A novel vascular smooth muscle chymase is upregulated in hypertensive rats.
  • Bradykinin B(2) receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates.
  • ACE inhibition in patients with myocardial infarct and ventricular dysfunction: inappropriate application of therapy standards in patient samples
  • Angiotensin converting enzyme inhibitors and cough--a north Indian study.
  • Renal multigated spectral Doppler imaging before and after captopril challenge.
  • Interaction of serotonin and cholecystokinin in the lateral parabrachial nucleus to control sodium intake.
  • Variable clinical response to long-term angiotensin inhibition in severe heart failure: demonstration of additive benefits of alpha-receptor blockade.
  • Synthesis of nonmammalian angiotensins and their comparative pressor properties in dogfish shark, domestic chicken, and rat.
  • Effect of nilvadipine in weak acidic medium by 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay.
  • Determination of captopril in tablets by gas chromatography (GC)
  • Effects of blockade of the renin-angiotensin system on tissue factor and plasminogen activator inhibitor-1 synthesis in human cultured monocytes.
  • Effect of captopril on mushroom tyrosinase activity in vitro.
  • Dose-dependent effects of angiotensin converting enzyme (ACE) inhibitors on glomerular prostanoid production by normotensive rats.
  • Differential effect of chronic antihypertensive treatment on vascular smooth muscle cell phenotype in spontaneously hypertensive rats.
  • The protective effect of captopril during myocardial ischemia and reperfusion and its mechanism
  • Direct separation of captopril diastereoisomers including their rotational isomers by RP-LC using a teicoplanin column.
  • Regulation of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: role of p42/44 mitogen-activated protein kinase and reactive oxygen species.
  • Three month subacute toxicity of captopril in beagle dogs
  • Direct, simplified, and sensitive assay of angiotensin II in plasma extracts performed with a high-affinity monoclonal antibody.
  • Maternal undernutrition increases arterial blood pressure in the sheep fetus during late gestation.
  • Angiotensin converting enzyme is the main contributor to angiotensin I-II conversion in the interstitium of the isolated perfused rat heart.
  • Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat.
  • Passive cigarette smoking induced changes in reactivity of the aorta in rabbits: effect of captopril.
  • Effects of various antihypertensive drugs on the function of osteoblast.
  • Captopril, a specific inhibitor of angiotensin converting enzyme, enhances both trypsin and vitellogenin titers in the grey fleshfly Neobellieria bullata.
  • Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
  • A thioesterase for chemoselective hydrolysis of S-acyl sulfanylalkanoates.
  • The protective effects of captopril and nitric oxide on solitary kidney after chronic partial ureteric obstruction.
  • Synaptic plasticity in sympathetic ganglia from acquired and inherited forms of ouabain-dependent hypertension.
  • Effect of antihypertensive therapy with captopril on gluco- and mineralocorticoid receptors of peripheral blood lymphocytes in hypertensive patients of various age
  • Verapamil prevents insulin antinatriuresis in euglycemic rats.
  • Molecular heterogeneity of angiotensin converting enzyme in human cerebrospinal fluid.
  • Effects of S-nitroso-N-acetyl-penicillamine administration on glucose tolerance and plasma levels of insulin and glucagon in the dog.
  • Bradykinin inhibits carotid sinus baroreflex in anesthetized rats
  • Effect of the prostacyclin analogue iloprost in sodium-depleted rats pretreated with captopril.
  • Perindopril + indapamide: new preparation. Simple trick.
  • Circulating angiotensin II mediates sodium appetite in adrenalectomized rats.
  • Effect of quercetin on tachykinin-induced plasma extravasation in rat urinary bladder.
  • Captopril and its time of administration in myocardial ischaemic-reperfusion injury.
  • Increased tyrosine nitration of the brain in chronic renal insufficiency: reversal by antioxidant therapy and angiotensin-converting enzyme inhibition.
  • Changes in the activity of the brain renin-angiotensin system and in the functional state of the pituitary-adrenal system of rats under the influence of captopril
  • Cerebrovascular effects of angiotensin converting enzyme inhibition involve large artery dilatation in rats.
  • Blunted renal responses to angiotensin II infusion in lifetime captopril-treated spontaneously hypertensive rats.
  • Solid-state trans-cis isomerization of captopril determined by thermal Fourier transform infrared (FT-IR) microspectroscopy.
  • In vitro contractile effects of neurokinin receptor blockade in the human ureter.
  • Effects of six antihypertensive drugs on blood pressure and hypothalamic GABA content in spontaneously hypertensive rats.
  • Rx drugs
  • Effect of losartan on sodium appetite of hypothyroid rats subjected to water and sodium depletion and water, sodium and food deprivation.
  • Activity of the renin-angiotensin-aldosterone system and its impact on the effectiveness of treatment of chronic heart failure in patients with pulmonary tuberculosis
  • Attenuation of the pressor activity of endogenous vasoconstrictors by sodium nitroprusside in the pithed rat.
  • Inhibitory effect of the angiotensin converting enzyme inhibitors captopril and enalapril on the conversion of procollagen to collagen.
  • Effects of antihypertensive treatment on cardiac hypertrophy and cardiac function in elderly hypertensive patients.
  • Detection of renal artery stenosis: prospective comparison of captopril-enhanced Doppler sonography, captopril-enhanced scintigraphy, and MR angiography.
  • CHF-1024, a DA2/alpha2 agonist, blunts norepinephrine excretion and cardiac fibrosis in pressure overload.
  • Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension.
  • Chromatographic detection of captopril using 4-dimenthylaminobenzaldehyde as spray reagent.
  • Acute effects of captopril and ibuprofen on proteinuria in patients with nephrosis.
  • Acute and subacute toxicity and efficacy of S-nitrosylated captopril, an ACE inhibitor possessing nitric oxide activities.
  • Corpuscles of Stannius secrete renin or an isorenin that regulates cardiovascular function in freshwater North American eels, Anguilla rostrata LeSueur.
  • Combined effect of captopril and thiazide diuretic on serum lipid profile in hypertensive women.
  • Changes in vasoreactivity of rat pulmonary artery after 7 d tail-suspension.
  • Dual inhibition of angiotensin converting enzyme and neutral endopeptidase by omapatrilat in rat in vivo.
  • Thermal dehydration-induced thirst in rats: role of angiotensin II.
  • Effect of angiotensin-converting enzyme inhibitor on renal function in ovarian hyperstimulation syndrome in the rabbit.
  • Intrarenal angiotensin II: interstitial and cellular levels and site of production.
  • Sympathetic modulation of renal blood flow by rilmenidine and captopril: central vs. peripheral effects.
  • Rx drugs
  • Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.
  • Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats.
  • Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart.
  • Effects of adhesives and permeation enhancers on the skin permeation of captopril.
  • Effects of angiotensin-converting enzyme inhibitors and cosaar on quality of life of patients with pulmonary tuberculosis and chronic heart failure
  • Biochemical and ultrastructural studies in the neural retina and retinal pigment epithelium of STZ-diabetic rats: effect of captopril.
  • Zinc metabolism in patients treated with captopril versus enalapril.
  • Clinical study on treatment of mild-middle degree congestive heart failure with integrated traditional Chinese and Western medicine
  • Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats.
  • Bradykinin enhances sympathetic neurotransmission in rat blood vessels.
  • Angiotensin I-converting enzyme inhibition increases cardiac catecholamine content and reduces monoamine oxidase activity via an angiotensin type 1 receptor-mediated mechanism.
  • Forebrain renin-angiotensin system has a tonic excitatory influence on renal sympathetic nerve activity.
  • Captopril inhibits secretin-induced pancreatic bicarbonate output.
  • Ischemic renal disease in Kuwait.
  • Optimisation and validation of an angiotensin-converting enzyme inhibition assay for the screening of bioactive peptides.
  • Dietary sodium restriction and the renin-angiotensin system in young spontaneously hypertensive rats.
  • Superoxide-superoxide oxidoreductase activity of the captopril-copper complex.
  • Hemodynamic effects of the treatment of hypertension with the calcium channel blocker diltiazem
  • Antihypertensive efficacy and effects on quality of life of captopril in mild-to-moderate arterial hypertension
  • Effect of captopril on left ventricular diastolic dysfunction in young insulin dependent diabetic patients with microalbuminuria
  • Non-contribution of renin-angiotensin system to pressor response to N(G)-nitro-L-arginine in dogs.
  • Effects of captopril and omapatrilat on early post-myocardial infarction survival and cardiac hemodynamics in rats: interaction with cardiac cytokine expression.
  • Presence of angiotensin-converting enzyme in follicular fluids of porcine ovaries and its possible involvement in the intrafollicular breakdown of bradykinin.
  • Captopril inhibits the pulmonary toxicity of paraquat in rats.
  • Clinical study on tangweikang capsule in treating diabetic nephropathy
  • Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor.
  • Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
  • Properties of selected S-nitrosothiols compared to nitrosylated WR-1065.
  • Angiotensin II receptors in the gonads.
  • Role of liquid membrane phenomenon in biological actions of ACE inhibitors, captopril and lisinopril.
  • Presence of angiotensin converting enzyme (ACE) interactive factors in ovaries of the grey fleshfly Neobellieria bullata.
  • Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors.
  • Antinociceptive action of captopril and transcutaneous electric nerve stimulation in Mus musculus mice.
  • Hypernociceptive syndromes and pharmacological inhibition of endogenous opioid degradation.
  • Determination of captopril plus its disulfide metabolites in human plasma
  • Mechanisms underlying the contraction induced by bradykinin in the guinea pig epithelium-denuded trachea.
  • Captopril angioscintigraphic test in the screening for renovascular hypertension in the light of long-term own observation (1098-2001)
  • Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.
  • Down-regulation of basal Fos expression at nucleus tractus solitarii underlies restoration of baroreflex response after antihypertensive treatment in spontaneously hypertensive rats.
  • Captopril--an inhibitor of the angiotensin I converting enzyme--in the treatment of arterial hypertension in chronic kidney failure patients
  • Hemodynamic state and the role of angiotensin II in ovarian hyperstimulation syndrome in the rabbit.
  • Effect of long-term prior antihypertensive treatment on cerebral ischemia induced by bilateral common carotid artery ligation in SHRSR
  • Captopril fails to reverse hypertrophy of the left ventricle induced by aortic insufficiency in rabbits.
  • Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
  • Prior treatment with captopril attenuates carbon tetrachloride-induced liver injury in mice.
  • Lipopolysaccharide induces apoptosis in adult rat ventricular myocytes via cardiac AT(1) receptors.
  • Use of angiotensin-converting enzyme inhibitors in chronic kidney insufficiency
  • Activation and suppression of renin-angiotensin system in human dendritic cells.
  • Secretory regulation of 19-hydroxyandrostenedione in normal man.
  • Flow injection chemiluminescence determination of captopril based on its enhancing effect on the luminol-ferricyanide/ferrocyanide reaction.
  • Effects of sodium intake on the captopril test for primary aldosteronism.
  • Separation and detection of angiotensin peptides by Cu(II) complexation and capillary electrophoresis with UV and electrochemical detection.
  • Role of endothelin receptors in the hypertensive state of kinin B(2) knockout mice subjected to a high-salt diet.
  • Crystal structures of leukotriene A4 hydrolase in complex with captopril and two competitive tight-binding inhibitors.
  • Forebrain circumventricular organs mediate salt appetite induced by intravenous angiotensin II in rats.
  • Dissociation between the circulating renin-angiotensin system and angiotensin II receptors in central losartan-induced hypertension.
  • Diuretic response to acute hypertension is blunted during angiotensin II clamp.
  • Degradation of nociceptin (orphanin FQ) by mouse spinal cord synaptic membranes is triggered by endopeptidase-24.11: an in vitro and in vivo study.
  • Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome.
  • Both dioscorin, the tuber storage protein of yam (Dioscorea alata cv. Tainong No. 1), and its peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activities.
  • Flow injection biamperometric determination of captopril.
  • Conversion of angiotensin-1 to angiotensin-2 by a latent endothelial cell peptidyl dipeptidase that is not angiotensin-converting enzyme.
  • Captopril in hypertension; seven years later.
  • High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives.
  • Inclusion complex formation of captopril with alpha- and beta-cyclodextrins in aqueous solution: NMR spectroscopic and molecular dynamic studies.
  • Met5enkephalin-Arg-Gly-Leu-induced antinociception is greatly increased by peptidase inhibitors.
  • Prognostic significance of captopril renography for managing congenital unilateral hydronephrosis.
  • Comparative effects of ACE inhibition and angiotensin II receptor blockade in the prevention of renal damage.
  • An economic evaluation of atenolol vs. captopril in patients with type 2 diabetes (UKPDS 24).
  • Kidney excretory function and the effect of furosemide following the chronic use of captopril in rats
  • Extracellular peptidases of imaginal discs of Drosophila melanogaster.
  • Novel peptides with orally active and long-lasting antihypertensive activity.
  • Functional characterization of tachykinin NK1 receptors in the mouse uterus.
  • The contribution of PGI2 to the effects of captopril in conscious dogs in differing states of sodium balance.
  • Kallikrein potentiation of angiotensin I-induced contraction on isolated mesenteric artery.
  • Acute and chronic systemic and pulmonary hemodynamic effects of angiotensin converting enzyme inhibition with captopril in hypertensive patients.
  • Role of kinin and prostaglandin in cutaneous thermal nociception.
  • Captopril treatment reverses erectile dysfunction in male stroke prone spontaneously hypertensive rats.
  • Increased cellular activity in rat insular cortex after water and salt ingestion induced by fluid depletion.
  • Three-dimensional structure of FEZ-1, a monomeric subclass B3 metallo-beta-lactamase from Fluoribacter gormanii, in native form and in complex with D-captopril.
  • Discovery and design of novel inhibitors of botulinus neurotoxin A: targeted 'hinge' peptide libraries.
  • Effects of dual angiotensin-converting enzyme and neutral endopeptidase 24-11 chronic inhibition by mixanpril on insulin sensitivity in lean and obese Zucker rats.
  • Captopril pharmacokinetics and the acute hemodynamic and hormonal response in patients with severe chronic congestive heart failure.
  • Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo.
  • Modern concepts in the drug treatment of arterial hypertension.
  • Patterns of antihypertensive agents use in 11,947 Colombian patients
  • Effect of vasopeptidase inhibitor omapatrilat on cardiomyocyte apoptosis and ventricular remodeling in rat myocardial infarction.
  • Downregulation of basal iNOS at the rostral ventrolateral medulla is innate in SHR.
  • Undesirable effects and interaction to angiotensin converting enzyme inhibitors therapy
  • The feedback regulation of angiotensinogen production by components of the renin-angiotensin system.
  • S-nitrosocaptopril: in vitro characterization of pulmonary vascular effects in rats.
  • Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeling and function of rats with chronic heart failure following left coronary artery ligation.
  • Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
  • Coordination geometries of metal ions in d- or l-captopril-inhibited metallo-beta-lactamases.
  • The 1.5-A structure of Chryseobacterium meningosepticum zinc beta-lactamase in complex with the inhibitor, D-captopril.
  • Enhancement by diuretics of the antihypertensive action of long-term angiotensin converting enzyme blockade.
  • Thiol-disulfide exchange yields multivalent dendrimers of melamine.
  • Captopril ameliorates myocarditis in acute experimental Chagas disease.
  • Influence of angiotensin converting enzyme inhibitors on stable myocardial ischemia in menopausal cardiac patients.
  • Immunolocalization of a microsomal prostaglandin E synthase in rabbit kidney.
  • Sympathetic responsiveness and plasma norepinephrine during therapy of chronic congestive heart failure with captopril.
  • Upregulation of cardiac insulin-like growth factor-I receptor by ACE inhibition after myocardial infarction: potential role in remodeling.
  • Midgut exopeptidase activities in Aedes aegypti are induced by blood feeding.
  • Combined effects of low-dose oral spironolactone and captopril therapy in a rat model of spontaneous hypertension and heart failure.
  • Elevated immunoreactive endothelin-1 levels in newborn rabbit lungs after meconium aspiration.
  • Cytomegalovirus myocarditis in a healthy infant: Complete recovery after ganciclovir treatment.
  • Renal and adrenal responses to converting-enzyme inhibition in fetal and newborn life.
  • Captopril prevents experimental autoimmune myocarditis.
  • Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport.
  • Time-dependent efficacy of antihypertensive agents in spontaneously hypertensive rats.
  • High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase.
  • Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
  • Angiotensin-converting enzyme activity in ovine bronchial vasculature.
  • Does ACE inhibitor modify the morphofunctional state of the nephron?
  • Role of endogenous angiotensin II on glutamatergic actions in the rostral ventrolateral medulla in Goldblatt hypertensive rats.
  • Influence of a kinin antagonist on acute hypotensive responses induced by bradykinin and captopril in spontaneously hypertensive rats.
  • Role of ultrasound dopplerography with acute captopril test in assessment of renal hemodynamics in chronic glomerulonephritis
  • The effects of captopril on the acute vascular responses to frusemide in man.
  • Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme.
  • Comparison of acute cardiovascular effects of cadmium and captopril in relation to oxidant and angiotensin converting enzyme activity in rats.
  • S-nitrosocaptopril: acute in-vivo pulmonary vasodepressor effects in pulmonary hypertensive rats.
  • A study of the determination of the hypertensive drug captopril by square wave cathodic adsorptive stripping voltammetry.
  • Increased vascular formation of angiotensin II in one-kidney, one clip hypertension.
  • Central tachykinin injection potently suppresses the need-free salt intake of the female rat.
  • Converting-enzyme inhibitors increase converting-enzyme mRNA and activity in endothelial cells.
  • Effect of calcium antagonists and other drugs on the hypoxia-induced increase in rat right ventricular pressure.
  • Effects of converting enzyme inhibition and alpha receptor blockade on the angiotensin pressor response in the American alligator.
  • Effect of resiniferatoxin on the isolated rabbit iris sphincter muscle: comparison with capsaicin and bradykinin.
  • Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure.
  • Exercise-induced proteinuria is attenuated by indomethacin.
  • Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure.
  • Impaired learning and memory in mature spontaneously hypertensive rats.
  • Elevated sympathetic nerve activity in patients with accelerated essential hypertension.
  • Rx drugs
  • Regulation of the angiotensin-converting enzyme activity by a time-course hypoxia in the carotid body.
  • Antioxidant properties of captopril in vitro.
  • Radionuclide renography: a review.
  • Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats.
  • Effect of angiotensin II antagonism on canine renal sympathetic nerve function.
  • Renal vasodilator responses to captopril in dogs pretreated with indomethacin.
  • Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors.
  • Age-related decline in spatial learning and memory: attenuation by captopril.
  • Age-dependent effects of captopril on the arterial baroreflex control of heart rate in conscious lambs.
  • ACE inhibitors and/or sartans in heart failure: is there a difference?
  • Membranous nephropathy: a 19 year prospective study in 51 patients.
  • Captopril enhanced insulin-stimulated glycogen synthesis in skeletal muscle but not fatty acid synthesis in adipose tissue of hereditary hypertriglyceridemic rats.
  • Increase in the kinin levels in the bronchial washings after intravenous injection of leukotriene C4 in guinea pigs.
  • Effect of a monoclonal antibody to angiotensin II on hemodynamic responses to noradrenergic stimulation in pithed rats.
  • AT1 receptor expression in glomeruli from NO-deficient rats.
  • The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress.
  • Botulinum A like type B and tetanus toxins fulfils criteria for being a zinc-dependent protease.
  • Antioxidant and anticataractogenic effects of topical captopril in diquat-induced cataract in rabbits.
  • Comparative effects of a vasopeptidase inhibitor vs. an angiotensin converting enzyme inhibitor on cardiomyocyte apoptosis in rats with heart failure.
  • Allylmercaptocaptopril: a new antihypertensive drug.
  • The preventive effect of captopril or enalapril on reperfusion injury of the kidney of rats is independent of angiotensin II AT1 receptors.
  • Evidence for bradykinin as a stimulator of thirst.
  • Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension.
  • Changes in Vascular Distensibility during Angiotensin-Converting Enzyme Inhibition Involve Bradykinin Type 2 Receptors.
  • Angiotensin converting anzyme (ACE) activity in porcine ocular tissue: effects of diet and ACE inhibitors.
  • Advances in hypertension management: Update 1998.
  • Application of data mining techniques in pharmacovigilance.
  • Relaxation of cat tracheobronchial and pulmonary arterial smooth muscle by vasoactive intestinal peptide: lack of influence by peptidase inhibitors.
  • The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat.
  • Early breakdown of dendritic bundles in the retrosplenial granular cortex of hypertensive rats: prevention by antihypertensive therapy.
  • An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis.
  • Hemodynamic effects of antihypertensive drugs on pregnancy-induced hypertension
  • Thirst and brain angiotensin in cattle.
  • Mechanism of the acute antihypertensive effect of captopril in patients on hemodialysis
  • Biologically active peptides from Bothrops jararacussu venom.
  • First dose hypotension after captopril; can it be predicted? A study of 240 patients.
  • Evidence for the involvement of sperm angiotensin converting enzyme in fertilization.
  • The influence of inhibitors of kinin biosynthesis, prostaglandins and angiotensin II on the vascular and tubular effects of strophanthin in the rat kidney
  • Effect of captopril on transplanted schistosome egg granulomas in skin.
  • Captopril in heart failure secondary to a left to right shunt.
  • Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols.
  • Oxidation of polyunsaturated fatty acids and lipids through thiyl and sulfonyl radicals: reaction kinetics, and influence of oxygen and structure of thiyl radicals.
  • Effect of the ACE-inhibitor captopril on the blood pressure and kidney function of patients with essential and renal hypertension
  • Captopril renal scintigraphy with 99mTc-mercaptoacetyltriglycine (99mTc-MAG3) for detecting renal artery stenosis.
  • Evaluation of the ability of the angiotensin-converting enzyme inhibitor captopril to scavenge reactive oxygen species.
  • Tubuloglomerular feedback in one-kidney, one-clip hypertensive rats.
  • Efficacy of various antihypertensive agents according to age and initial arterial pressure
  • Additive combination studies of captopril and ditekiren, a renin inhibitor, in nonhuman primates.
  • Perspectives of drug therapy in heart failure.
  • Captopril, an ACE inhibitor, for optimizing reperfusion after acute myocardial infarction.
  • Hydrolysis of angiotensin I by peptidases in homogenates of rat lung and aorta.
  • A reliable radiometric assay for the determination of angiotensin I-converting enzyme activity in urine.
  • Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension. Response to captopril.
  • Antihypertensive action of a procyanidin glycoside from Rhamnus lycioides.
  • Effects of angiotensin II on pressor responses to norepinephrine in humans.
  • Influence of various antihypertensive agents on lifespan of renal hypertensive rats.
  • Does endocardial endothelium mediate positive inotropic response to angiotensin I and angiotensin II?
  • Captopril and enalaprilat do not scavenge the superoxide anion.
  • Brain kinins are responsible for the pressor effect of intracerebroventricular captopril in spontaneously hypertensive rats.
  • Adverse effects of captopril in hospital outpatients with hypertension.
  • Use of tensiomin (captopril) in the antihypertensive treatment of haemodialysis patients.
  • Mortality in patients treated with captopril for left ventricular dysfunction following myocardial infarction.
  • Interaction of captopril and ibuprofen on glomerular and tubular function in humans.
  • Effect of captopril on renal function in hypertensive dogs with unilateral renal artery stenosis, studied with radionuclide dynamic scintigraphy.
  • Hypotensive action of Salvia miltiorrhiza cell culture extract.
  • Significance of single-dose captopril test in the differential diagnosis of primary aldosteronism
  • Effects of antihypertensive therapy on the renal function in spontaneously hypertensive rats (SHR) with renal ablation
  • Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats.
  • Biological properties of the angiotensin-converting enzyme inhibitor cilazapril.
  • Effects of converting-enzyme inhibition on cardiorenal hemodynamics in patients with chronic congestive heart failure.
  • Metabolism of neuropeptides. Hydrolysis of the angiotensins, bradykinin, substance P and oxytocin by pig kidney microvillar membranes.
  • Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra.
  • Effects of long-term treatments with captopril on blood pressure and renin activity in the stroke-prone spontaneously hypertensive rats.
  • Regulation of inactive renin secretion: studies with aprotinin.
  • The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
  • In vivo metabolism of atrial natriuretic peptide: identification of plasma metabolites and enzymes responsible for their generation.
  • The renin-angiotensin system during pregnancy in chronically instrumented, conscious rats.
  • Degradative enzymes modulate airway responses to intravenous neurokinins A and B.
  • Reduction of the antihypertensive effect of captopril induced by prostaglandin synthetase inhibition.
  • Importance of venodilatation in prevention of left ventricular dilatation after chronic large myocardial infarction in rats: a comparison of captopril and hydralazine.
  • Renography with captopril in renal transplant recipients.
  • Action of the antihypertensive effect of captopril on manifestations of hypertrophy and several parameters of myocardial metabolism
  • Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites
  • Effect of captopril treatment on proteinuria in NZB/NZW F1 hybrid mice.
  • Comparison of immunoreactive renin and plasma renin activity in human plasma.
  • Post-transplant hypertension in the rat: effects of captopril and native nephrectomy.
  • Angiotensin formation in the isolated rat hindlimb.
  • Captopril (Tensiomin) in the treatment of chronic heart failure of ischaemic heart disease patients.
  • Cadmium-induced hypertension in rats.
  • Time course of antihypertensive effect of low-dose captopril in mild to moderate hypertension.
  • Captopril-stimulated plasma renin activity in the diagnosis of renovascular hypertension
  • A unique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studies.
  • Converting enzyme inhibition resets cerebral autoregulation at lower blood pressure.
  • Treatment of hypertension in dialysis patients.
  • Vasodilators in the treatment of hypertension.
  • In vitro and in vivo release of neurokinin A-like immunoreactivity from rat substantia nigra.
  • Role of sodium in modulation of myocardial hypertrophy in renal hypertensive rats.
  • Direct effect of alpha-human atrial natriuretic peptide on human vasculature in vivo and in vitro.
  • Effect of atrial natriuretic factor (ANF) on the secretory activity of zona glomerulosa in sodium-restricted rats.
  • Decreased pressor reactivity to angiotensin II in cirrhotic rats. Evidence for a post-receptor defect in angiotensin action.
  • Direct hypotensive action of intravascular bradykinin in man.
  • Chronic effects of enalapril on blood pressure, stroke, plasma renin, urinary electrolytes and PGE2 excretion in stroke-prone spontaneously hypertensive rats.
  • Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.
  • Effects of converting enzyme inhibition on split renal function in renovascular hypertension.
  • Renal effects of angiotensin converting enzyme inhibitors in hypertension.
  • Captopril in treatment-resistant essential and renal hypertension.
  • Hypertension therapy in the elderly. Our experience with converting enzyme inhibitors
  • Kininase II of human seminal fluid: kinetics and inhibition.
  • New blood pressure lowering drugs in childhood
  • A comparison of antihypertensive properties of captopril and enalapril after single and multiple oral administration in spontaneously hypertensive rats.
  • Hypotensive effect of SA446, an angiotensin converting enzyme inhibitor, in 2-kidney, 1-clip renal hypertensive and normotensive dogs.
  • Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor.
  • Controlled release captopril microcapsules: effect of non-ionic surfactants on release from ethyl cellulose microcapsules.
  • Control of hypertension with the angiotensin converting enzyme inhibitor captopril reduces glomerular proteinuria.
  • Combined captopril treatment in severe and moderately severe hypertension resistant to therapy.
  • Pulmonary vascular responses to angiotensin II and captopril in conscious dogs.
  • Contribution of the kidneys but not adrenal glands to the acute antihypertensive effects of captopril in spontaneously hypertensive rats.
  • A reaction between captopril (a high blood pressure drug) and gold(I)-thiomalate.
  • Prostanoids in renal failure induced by converting enzyme inhibition in sodium-depleted rats.
  • Contrasting acute effects of captopril and nifedipine on renal function in renovascular hypertension.
  • The combination of verapamil and captopril in the treatment of essential hypertension.
  • Inhibition of the antihypertensive activity of intravenous captopril by pretreatment with indomethacin
  • Re-examination of the effect of either a lateral or third ventricular cannula on captopril-induced salt appetite in rats.
  • Converting enzyme inhibition and progressive glomerulosclerosis in the rat.
  • Autoregulation of glomerular blood flow during converting-enzyme inhibition by captopril.
  • Drug-protein conjugates--XV. A study of the disposition of D-penicillamine in the rat and its relationship to immunogenicity.
  • The clinical significance of the anticentromere antibody.
  • The effects of chronic treatment with captopril in spontaneously hypertensive rats (SHR) and their offspring.
  • Effect of captopril on blood pressure responses to enkephalins in chloralose-anaesthetized rats.
  • Low-dose captopril alone and in combination with hydrochlorothiazide in the treatment of mild to moderate essential hypertension.
  • Converting enzyme inhibitors for the treatment of hypertension in the elderly.
  • Maintenance of the antihypertensive efficacy of captopril despite consistent reduction in daily dosage.
  • Pathogenesis of nonocclusive ischemic colitis.
  • The effects of captopril (SQ 14,225) on bradykinin-induced bronchoconstriction in the anesthetized guinea pig.
  • Effect of angiotensin II and captopril on renal tubular function in man.
  • Renal responses to hypoxemia during renin-angiotensin system inhibition in fetal lambs.
  • Acute and chronic effects of captopril on the renin-angiotensin and kallikrein-kinin systems affecting blood pressure and natriuresis.
  • Effect of captopril on heavy proteinuria in azotemic diabetics.
  • The effect of captopril treatment on potassium-induced stimulation of aldosterone production in vitro.
  • Inhibition of hydrolytic activities of human dipeptidases toward leukotriene D4 and kyotorphin by captopril.
  • The effects of diltiazem and captopril on glycerol-induced acute renal failure in the rat. Functional, pathologic, and microangiographic studies.
  • Ergometric evaluation of the effects of captopril in hypertensive patients with stable angina.
  • Captopril therapy in chronic congestive heart failure.
  • Effects of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone system in normal subjects and hypertensive patients with various etiologies
  • Urinary excretion of zinc in patients with essential arterial hypertension.
  • Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
  • Sodium appetite decreased by central angiotensin blockade.
  • Combined treatment of severe intractable hypertension with captopril and diuretic.
  • Analysis of the mechanism of acute decrease of blood pressure induced by captopril (SQ 14,225) in dogs by the use of aprotinin, SAR1-ILE8-angiotensin II and indomethacin.
  • Experience with captopril treatment.
  • On the mechanism of serotonin-induced dipsogenesis in the rat.
  • Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
  • Effect of captopril on renal vascular resistance, renin, prostaglandins and kinin in the isolated perfused kidney.
  • Trends in prescribing of antihypertensive drugs in Australia, 1977-1987.
  • Effects of captopril (SQ 14, 225) on the renin-angiotensin-aldosterone system in normal rats.
  • Potassium ion as a regulator of adrenal angiotensin II receptors.
  • Converting enzyme inhibition during chronic angiotensin II infusion in rats. Evidence against a nonangiotensin mechanism.
  • Regulation of uterine smooth muscle bradykinin receptors by bradykinin levels and angiotensin converting enzyme inhibitor in the rat.
  • Immunohistochemical evidence that angiotensins I and II are formed by intracellular mechanism in juxtaglomerular cells.
  • Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
  • Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
  • Rat paw edema induced by trimucase II, a kinin-releasing enzyme from Trimeresurus mucrosquamatus venom.
  • Effects of converting enzyme inhibition with captopril on renal function in normal and ACTH treated sheep.
  • The design of a new group of angiotensin-converting enzyme inhibitors.
  • In vivo evaluation of the antagonist activity of angiotensin I analogs.
  • The induction of angiotensin converting enzyme by its inhibitors.
  • Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)
  • Estimation of angiotensin II receptor activity in chronic congestive heart failure.
  • Converting enzyme inhibition in the rat by captopril is accompanied by potentiation of carrageenin-induced inflammation.
  • Combined vasodilator therapy for chronic congestive heart failure.
  • Pharmacologic alterations in Tc-99m binding by red blood cells: concise communication.
  • Effect of captopril on blood pressure, renal function, the electrolyte balance and the renin-angiotensin system in Bartter's syndrome.
  • Angiotensin II facilitates tricyclic antidepressant-induced changes in QRS-duration in the rat.
  • Development and optimisation of a radioimmunoassay for plasma captopril.
  • Primary hyperaldosteronism: diagnostic value of the administration of a single dose of captopril
  • Renal hemodynamic effects of captopril in anesthetized sodium-restricted dogs. Relative contributions of prostaglandin stimulation and suppressed angiotensin activity.
  • Cardiovascular effects of antihypertensive drugs as affected by dietary polyunsaturates.
  • Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses.
  • Acute effect of captopril on serum lipid peroxides level in hypertensive patients.
  • Indomethacin and angiotensin II pressor responsiveness: importance of dietary sodium.
  • The renin-angiotensin system and sodium appetite.
  • Tachycardic responses during the development of renal hypertension.
  • A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
  • Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
  • Factors predicting acute and long-term response to captopril therapy in congestive heart failure.
  • Long-term captopril therapy: evolving hemodynamic effects.
  • Distribution of captopril to foetuses and milk of rats.
  • Proteinuria during long-term captopril therapy.
  • Synthesis and biological activity of a ketomethylene analogue of a tripeptide inhibitor of angiotensin converting enzyme.
  • Interaction of minoxidil and captopril in the treatment of refractory hypertension.
  • Indication for central vagal endorphinergic control of heart rate in dogs.
  • Captopril in the therapy of hypertensive nephropathy
  • Effects of meclofenamate and captopril on renal and other regional vascular beds after mild haemorrhage in conscious rabbits.
  • Effects of the subcutaneous administration of enkephalins on tail-flick response and righting reflex of developing rats.
  • Prophylaxis of bone marrow transplant nephropathy with captopril, an inhibitor of angiotensin-converting enzyme.
  • Rise in plasma concentration of aldosterone during long-term angiotensin II suppression.
  • Captopril attenuates pressor responses to norepinephrine and vasopressin through depletion of endogenous angiotensin II.
  • Single-dose captopril test and captopril renal scintigraphy in the evaluation of renovascular hypertension
  • Effect of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive patients on hemodialysis.
  • Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats.
  • Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension.
  • Pharmaclinics. Drug of the month. Captopril (Capoten) in diabetic nephropathies
  • Alterations of methionine fluxes and incorporation in intestines of miniature pigs fed a diet high in caseinate are restricted by angiotensin-converting enzyme inhibitor.
  • Both low sodium and high potassium intake increase the level of adrenal angiotensin-II receptor type 1, but not that of adrenocorticotropin receptor.
  • Influence of theophylline on both bronchoconstriction and plasma extravasation induced by acetaldehyde in guinea-pigs.
  • Abnormal glomerular and tubular function during angiotensin converting enzyme inhibition in renovascular hypertension evaluated by the lithium clearance method.
  • Efficacy of angiotensin-converting enzyme inhibition and AT1 receptor blockade on cardiac pump performance after myocardial infarction in rats.
  • Analysis of responses to bradykinin in the pulmonary vascular bed of the cat.
  • Assessment of flosequinan's direct effect on human arterial, venous, and cardiac muscle: comparison with other classes of agents used to treat heart failure.
  • Mechanism of the action of angiotensin-converting enzyme inhibitors on agonist-induced Ca2+ influx.
  • Effect of captopril treatment on total and central vascular capacitance in dogs with chronic heart failure.
  • Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs.
  • Tachykinin NK3 receptor mediates NANC hyperpolarization and relaxation via nitric oxide release in the circular muscle of the guinea-pig colon.
  • Remodeling of the rat right and left ventricles in experimental hypertension.
  • Neutral endopeptidase modulates substance P-induced vasodilation in vivo.
  • Long-term effects of antihypertensive treatment and good glycemic control on plasma lipids in diabetic rats.
  • Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations.
  • Captopril in improving vascular structure and lowering blood pressure
  • Renin-aldosterone axis in normoalbuminuric insulin-dependent diabetes mellitus patients with glomerular hyperfiltration.
  • Effects of chronic losartan treatment on myocardial, vascular structure and reactivity with aging in spontaneously hypertensive rats (SHR): its effects compared with those of captopril
  • Antihypertensive effects of captopril without adverse effects on glucose tolerance in hyperinsulinemic rhesus monkeys.
  • Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus.
  • A study of zinc-dependent metalloendopeptidase inhibitors as pharmacological antagonists in botulinum neurotoxin poisoning.
  • Renovascular hypertension: a noninvasive screening approach using captopril renography.
  • ACE inhibition prevents Na and water retention and MABP increase during reduction of renal perfusion pressure.
  • Effect of captopril on acetylcholine-induced relaxation in the presence of nitroglycerin tolerance in isolated rabbit aorta.
  • Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.
  • The endogenous tripeptide Tyr-Gly-Gly as a possible metabolite of opioid peptides in rat brain: identification, regional distribution, effects of lesions and formation in depolarized slices.
  • In vivo studies of the control of DNA synthesis in the rat adrenal cortex and medulla.
  • Viral infection potentiates the increase in airway blood flow produced by substance P.
  • Regulatory system and physiological significance of local factors in the ovary during follicular development and maturation
  • Recombinant human hemoglobin (rHb1.1) selectively inhibits vasorelaxation elicited by nitric oxide donors in rabbit isolated aortic rings.
  • Isolation and characterization of a new bradykinin potentiating octapeptide from gamma-casein.
  • The prooxidant properties of captopril.
  • Comparison of the transplacental transfer of enalapril, captopril and losartan in sheep.
  • Analysis of responses to angiotensin peptides in the hindquarters vascular bed of the cat.
  • Captopril attenuates reflex adrenergic response in essential hypertension.
  • Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study.
  • Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure
  • Anaphylactoid reactions during haemodialysis in sheep are associated with bradykinin release.
  • Angiotensin I- and II- and norepinephrine-mediated pressor responses in an ancient holostean fish, the bowfin (Amia calva).
  • Association of left ventricular remodeling and nonuniform electrical recovery expressed by nondipolar QRST integral map patterns in survivors of a first anterior myocardial infarction. Captopril and Thrombolysis Study Investigators.
  • Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production.
  • Effect of captopril and angiotensin II receptor blockade on pressure natriuresis in transgenic TGR(mRen-2)27 rats.
  • Captopril and other angiotensin converting enzyme inhibitors in the treatment of hypertension
  • Conversion and degradation of 125I labelled angiotensin I in isolated perfused porcine coronary and carotid arteries.
  • Study of the rat adrenal renin-angiotensin system at a cellular level.
  • The renin-angiotensin system--a possible neuromodulator in the human retina?
  • Effects of captopril on the human foetal placental circulation: an interaction with bradykinin and angiotensin I.
  • Effects of captopril on the urinary excretion of prostanoids and kallikrein in spontaneously hypertensive rats.
  • Evidence for peptidase activity in the rat intestine.
  • The interconnection between the activity of carboxypeptidase N and angiotensin-converting enzyme
  • Role of the tissue renin-angiotensin system in the action of angiotensin-converting enzyme inhibitors.
  • Endothelin in renovascular and essential hypertension.
  • Role of renin-angiotensin system in blood pressure regulation in pregnancy.
  • Captopril normalises systolic blood pressure in rats with hypertension induced by fetal exposure to maternal low protein diets.
  • Comparative assessment of digoxin and captopril in the treatment of chronic congestive circulatory failure, NYHA grade II
  • Captopril cardioplegia on myocardial protection in the hypertrophied rat hearts.
  • Regression of left ventricular hypertrophy prevents ischemia-induced lethal arrhythmias. Beneficial effect of angiotensin II blockade.
  • Resistant hypertension: what to do after trying 'the usual'.
  • Two routes for 99mTc-DMSA uptake into the renal cortical tubular cell.
  • Enzyme immunoassay for serum 18-hydroxycorticosterone and its clinical application
  • Treatment in hypertensive cardiac hypertrophy, II. Postreceptor events.
  • The beneficial effect of low initial dose and gradual increase of erythropoietin treatment in hemodialysis patients.
  • Increased alcohol consumption in weight-reduced rats is modulated by the renin-angiotensin system.
  • General internal medicine.
  • Captopril scintirenography: a protocol to assess efficacy and methodology. A collaborative study.
  • Two-year clinical follow-up of children and adolescents after percutaneous transluminal angioplasty for renovascular hypertension.
  • Ultraviolet (UV) absorption and circular dichroism (CD) spectra of captopril.
  • Use of captopril in diabetics
  • Mechanisms and modulation of airway plasma exudation after direct inhalation of cigarette smoke.
  • The effects of captopril in arterial proliferative response after intima balloon denudation
  • Reduction of plasma and urinary vasopressin during treatment of severe hypertension by captopril.
  • Large artery remodeling after myocardial infarction.
  • In vivo measurements of pulmonary angiotensin-converting enzyme kinetics. II. Implementation and application.
  • Clinical effect of captopril on the formation and growth of cystine calculi.
  • Involvement of B1 and B2 receptors in bradykinin-induced rat paw oedema.
  • The interaction of the converting-enzyme inhibitor captopril with cardiac glycosides in the rat kidney
  • Effects of cicletanine on kidney function. 2. Role of renal prostaglandins and kinins, and of muscarinic receptors.
  • Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum.
  • Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments.
  • Exaggerated blood pressure response to angiotensin II in patients with Cushing's syndrome due to adrenocortical adenoma.
  • Socioeconomic aspects of ACE inhibition in the secondary prevention in cardiovascular diseases.
  • Effect of captopril on urinary excretion of renin and angiotensinogen in aminonucleoside nephrosis.
  • Characterization of a method for the detection of drugs with free radical scavenging activity using porcine leukocytes.
  • Blood pressure after captopril withdrawal from spontaneously hypertensive rats.
  • Acute hemodynamic effects of drugs acting on the renin-angiotensin system in acute heart failure.
  • Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors.
  • Facilitation by procaterol, a beta-adrenoceptor agonist, of noradrenaline release in the pithed rat independently of angiotensin II formation.
  • The effect of angiotensin I converting enzyme inhibitors on renal function indicators in hypertensive patients
  • Analysis of responses to ANG IV: effects of PD-123319 and DuP-753 in the pulmonary circulation of the rat.
  • Selective proteolitic activation and degradation of ETs and big ETs in parenchymal strips of the guinea-pig lung.
  • A study of captopril enhancement of nitrate effect coronary arterial disease patients associated with heart failure
  • Efficacy of captopril treatment in children with steroid-resistant nephrotic syndrome.
  • The effects of captopril on blood pressure, urinary water and electrolyte excretion and drinking behaviour in Brattleboro rats.
  • The clinician's need in renovascular hypertension
  • Angiotensin-converting enzyme activity and contractile effects of angiotensin I and II in human uteroplacental arteries.
  • Involvement of angiotensin in water intake induced by peripheral administration of a serotonin agonist, 5-carboxyamidotryptamine.
  • Differential inhibition of platelet aggregation and calcium mobilization by nitroglycerin and stabilized nitric oxide.
  • Pressor responses to the alpha 1-adrenoceptor agonist cirazoline: effects of captopril, phenoxybenzamine and nifedipine.
  • Influences of different antihypertensive treatments on indices of systemic mineral metabolism.
  • Identification and subcellular localization of leukotriene A4-hydrolase activity in human epidermis.
  • Evidence for a renovascular component in hypertensive patients with late radiation nephropathy.
  • Specificity and directionality of thiol effects on sinusoidal glutathione transport in rat liver.
  • Concentrations of kininogen and prekallikrein in plasma and activity of plasma renin depending on the type of blood pressure response to captopril in patients with arterial hypertension
  • Normalization of active urinary kallikrein excretion by young spontaneously hypertensive rats by chronic inhibition of conversion enzyme
  • Initiation of rat vasopressin cell responses to simulated hypotensive hemorrhage.
  • ACE inhibitor-mediated attenuation of mesangial cell growth. A role for endothelin.
  • Captopril versus enalapril: a comparison of 24 h humoral and hypotensive effects.
  • Lack of involvement of the kallikrein-kinin system in the depressor effect of alpha-methyldopa in normotensive rats.
  • Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage.
  • Regression of cardiac hypertrophy and myosin isoenzyme patterns by losartan and captopril in renovascular hypertensive rats.
  • Direct vascular smooth muscle contractile effect of cyclosporin A and its vehicle in rabbit isolated arteries.
  • Action of angiotensin converting enzyme inhibitors in rat brain: interaction with isoproterenol assessed by Fos immunocytochemistry.
  • Synaptobrevin cleavage by the tetanus toxin light chain is linked to the inhibition of exocytosis in chromaffin cells.
  • Bradykinin-induced contraction of guinea pig lung in vitro.
  • Renal duplex: clinical usefulness
  • Captopril inhibits the agonist-induced increase of cytosolic free Ca2+ in glomerular mesangial cells.
  • Blood pressure responses to substances interfering with nitric oxide formation, cyclooxygenase and converting enzyme activities and vasopressin V1 receptors blockade in conscious spontaneously hypertensive and normotensive rats.
  • Influence of prolonged application of captopril upon pulmonary ventilation in patients with chronic congestive heart failure
  • Sympatholytic effect of captopril in regression of cardiovascular remodeling in spontaneously hypertensive rats.
  • Lack of interaction of angiotensin converting enzyme inhibitors with muscarinic and neuropeptide Y receptors.
  • Effects on binding characteristics and renal function of the novel, non-peptide angiotensin II antagonist BIBR277 in the rat.